MEN syndromes are classic “pattern recognition” questions on Step 1/2: a stem drops hypercalcemia, a thyroid nodule, or refractory peptic ulcers, and you’re supposed to snap to the right constellation—fast. Here are 3 quick, shareable tips (with a mnemonic + one-liner each) to nail MEN1 vs MEN2A vs MEN2B, with extra emphasis on the calcium/bone metabolism angles that show up all the time.
Tip #1: MEN1 = “3 P’s” (and hypercalcemia is usually the first clue)
Visual / mnemonic device
MEN1 = 3 P’s
Parathyroid, Pancreas, Pituitary
Think: “MEN1 starts with calcium.” When you see stones, bones, groans, ask: What else is in the triad?
One-liner (high-yield)
MEN1 is a tumor suppressor gene (menin) mutation → parathyroid hyperplasia/adenomas → primary hyperparathyroidism → hypercalcemia.
What to memorize (USMLE-style bullets)
- Most common + often earliest manifestation: Primary hyperparathyroidism (parathyroid hyperplasia > adenoma).
- Calcium/bone angle: High PTH → increased bone resorption → bone pain, fractures, osteopenia/osteitis fibrosa cystica (advanced).
- Labs in MEN1 hyperPTH:
- PTH, Ca, PO
- ALP may be present from high bone turnover
- Pancreatic neuroendocrine tumors (NETs): gastrinoma (Zollinger-Ellison), insulinoma, VIPoma, glucagonoma.
- Gastrinoma clue: recurrent/refractory ulcers + diarrhea.
- Pituitary: prolactinoma (most common), GH-secreting, ACTH-secreting.
Quick differentiation hook
If the stem leads with hypercalcemia and mentions ulcers/diarrhea or pituitary symptoms, your reflex should be MEN1.
Tip #2: MEN2A = “MTC + Pheo + Parathyroid” (RET = “REarranged during Transfection”)
Visual / mnemonic device
MEN2A = “2A = 2 glands + A little extra”
- Thyroid (Medullary)
- Adrenal (Pheo)
- + Parathyroid
Or simply: MEN2A = MTC + Pheo + Parathyroid.
One-liner (high-yield)
MEN2A is an autosomal dominant activating mutation in the RET proto-oncogene → medullary thyroid carcinoma + pheochromocytoma + primary hyperparathyroidism.
What to memorize (USMLE-style bullets)
- Medullary thyroid carcinoma (MTC):
- From parafollicular C cells → secretes calcitonin
- Amyloid stroma (from calcitonin)
- Can cause diarrhea/flushing (hormone secretion)
- Pheochromocytoma:
- Episodic headache, sweating, tachycardia, hypertension
- Rule: treat/block alpha before beta
- Calcium/bone angle in MEN2A:
- Can have primary hyperparathyroidism → hypercalcemia (similar lab pattern to MEN1)
- Test loves to contrast MEN2A (sometimes hyperCa) vs MEN2B (no parathyroid)
Step-style pearl: “Thyroid nodule + high calcitonin”
If there’s a thyroid mass and calcitonin is elevated, think MTC. Then ask: Is there hypercalcemia (2A) or mucosal neuromas/marfanoid (2B)?
Tip #3: MEN2B = “MTC + Pheo + Neuromas (no parathyroid)” → marfanoid vibe
Visual / mnemonic device
MEN2B = “B for Bumps + Body habitus”
- Bumps: mucosal neuromas (lips/tongue)
- Body: marfanoid habitus
- Still has MTC + Pheo
- No parathyroid involvement (that’s the key calcium distinction)
One-liner (high-yield)
MEN2B is RET activation → medullary thyroid carcinoma + pheochromocytoma + mucosal neuromas/marfanoid habitus (typically no hyperparathyroidism).
What to memorize (USMLE-style bullets)
- Mucosal neuromas: painless nodules on lips, tongue, oral mucosa; “bumpy lips.”
- Marfanoid habitus: tall, long limbs; but not necessarily the ocular/cardiac features you’d lean on for Marfan.
- Calcium/bone angle: generally no primary hyperparathyroidism, so hypercalcemia is not a defining feature.
- Clinical priority: MTC can be aggressive—screen early in RET-positive families.
Rapid-fire table: MEN1 vs MEN2A vs MEN2B (the exam sorter)
| Syndrome | Gene | Core tumors | Calcium clue | Signature “tell” |
|---|---|---|---|---|
| MEN1 | MEN1 (menin), tumor suppressor | Parathyroid, pancreatic NETs, pituitary | Hypercalcemia common/early (primary hyperPTH) | “3 P’s” + ulcers/diarrhea or pituitary sx |
| MEN2A | RET activation, proto-oncogene | MTC, Pheo, Parathyroid | Can have hypercalcemia (primary hyperPTH) | MTC + episodic HTN + maybe hyperCa |
| MEN2B | RET activation, proto-oncogene | MTC, Pheo, mucosal neuromas | No parathyroid (hyperCa not typical) | Bumpy lips + marfanoid |
Micro-mnemonic: “Who gets hypercalcemia?”
Use this as a 2-second tie-breaker:
- MEN1: Yes (very common)
- MEN2A: Yes (possible)
- MEN2B: No (classically)
High-yield test traps (don’t fall for these)
- “Calcitonin lowers calcium, so MTC should cause hypocalcemia.”
On exams, MTC is a marker tumor (calcitonin/amyloid/RET)—it usually doesn’t present with hypocalcemia. Hypercalcemia points you more toward parathyroid disease (MEN1, MEN2A). - Confusing MEN2B with MEN2A because both have MTC + pheo:
Look for mucosal neuromas/marfanoid (→ 2B) vs parathyroid hyperplasia/hypercalcemia (→ 2A). - Pheo management order:
Alpha blockade first, then beta blockade (prevent unopposed alpha vasoconstriction).
Ultra-quick “stem to syndrome” mapping
- Recurrent ulcers + high gastrin + hypercalcemia → MEN1
- Thyroid nodule + high calcitonin + episodic headaches/sweats → MEN2A or MEN2B
- Add hypercalcemia → MEN2A
- Add mucosal neuromas/marfanoid → MEN2B